持续发展，向下一个百年迈进
本公司由五大部门构成，以开发为社会贡献的产品为目标。
产品信息
Price Revision for Denka Chloroprene
IR信息
Notice Regarding Results of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)
Announcement of Extraordinary Gains (Gain on Sale of Investment Securities)
Summary of Q&A Session for Management Presentation on Feb 27 2026
Notice Concerning Change in Equity-Method Affiliate (Becoming a Consolidated Subsidiary)
Presentation Materials for Management Presentation on Feb 27 2026 with Script
(Amendment) Notice Regarding Amendment to “Notice Regarding Commencement of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)” and Public Notice of Commencementof Tender Offer Dueto Filingof Amendment Statement
